Synthesis, In Silico and Kinetics Evaluation of N-(β-d-glucopyranosyl)-2-arylimidazole-4(5)-carboxamides and N-(β-d-glucopyranosyl)-4(5)-arylimidazole-2-carboxamides as Glycogen Phosphorylase Inhibitors
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25094591 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Levente Homolya und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Organic Chemistry, University of Debrecen, POB 400, H-4002 Debrecen, Hungary. Hauptthemen laut MEDLINE: Molecular Docking Simulation, Enzyme Inhibitors, Glycogen Phosphorylase, Imidazoles. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hungarian National Research, Development and Innovation Office, European Regional Development Fund, Gedeon Richter Talentum Foundation.
Abstract (Originalsprache)
Recently studied N-(β-d-glucopyranosyl)-3-aryl-1,2,4-triazole-5-carboxamides have proven to be low micromolar inhibitors of glycogen phosphorylase (GP), a validated target for the treatment of type 2 diabetes mellitus. Since in other settings, the bioisosteric replacement of the 1,2,4-triazole moiety with imidazole resulted in significantly more efficient GP inhibitors, in silico calculations using Glide molecular docking along with unbound state DFT calculations were performed on N-(β-d-glucopyranosyl)-arylimidazole-carboxamides, revealing their potential for strong GP inhibition. The syntheses of the target compounds involved the formation of an amide bond between per-O-acetylated β-d-glucopyranosylamine and the corresponding arylimidazole-carboxylic acids. Kinetics experiments on rabbit muscle GPb revealed low micromolar inhibitors, with the best inhibition constants (Kis) of ~3–4 µM obtained for 1- and 2-naphthyl-substituted N-(β-d-glucopyranosyl)-imidazolecarboxamides, 2b–c. The predicted protein–ligand interactions responsible for the observed potencies are discussed and will facilitate the structure-based design of other inhibitors targeting this important therapeutic target. Meanwhile, the importance of the careful consideration of ligand tautomeric states in binding calculations is highlighted, with the usefulness of DFT calculations in this regard proposed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Organic Chemistry, University of Debrecen, POB 400, H-4002 Debrecen, Hungary.
- School of Pharmacy & Biomedical Sciences, University of Central Lancashire, Preston PR1 2HE, UK.
- Department of Medical Chemistry, Faculty of Medicine, University of Debrecen, Egyetem tér 1, H-4032 Debrecen, Hungary.
ORCID-Profile: Levente Homolya, László Juhász, Joseph M Hayes, László Somsák
Förderung
- Hungarian National Research, Development and Innovation Office
- European Regional Development Fund
- Gedeon Richter Talentum Foundation
- Sydney Driscoll Neuroscience Foundation (SDNF)
Zitieren
APA
Homolya, L., Mathomes, R. T., Varga, L., Docsa, T., Juhász, L., Hayes, J. M., & Somsák, L. (2024). Synthesis, In Silico and Kinetics Evaluation of N-(β-d-glucopyranosyl)-2-arylimidazole-4(5)-carboxamides and N-(β-d-glucopyranosyl)-4(5)-arylimidazole-2-carboxamides as Glycogen Phosphorylase Inhibitors. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25094591
Vancouver
Homolya L, Mathomes RT, Varga L, Docsa T, Juhász L, Hayes JM, et al. Synthesis, In Silico and Kinetics Evaluation of N-(β-d-glucopyranosyl)-2-arylimidazole-4(5)-carboxamides and N-(β-d-glucopyranosyl)-4(5)-arylimidazole-2-carboxamides as Glycogen Phosphorylase Inhibitors. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25094591
BibTeX
@article{Homolya2024,
author = {Homolya, Levente and Mathomes, Rachel T and Varga, Luca and Docsa, Tibor and Juhász, László and Hayes, Joseph M and Somsák, László},
title = {Synthesis, In Silico and Kinetics Evaluation of N-(β-d-glucopyranosyl)-2-arylimidazole-4(5)-carboxamides and N-(β-d-glucopyranosyl)-4(5)-arylimidazole-2-carboxamides as Glycogen Phosphorylase Inhibitors},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25094591}
}
EUVIMED